Located on Chromosome 17, this mutation impacts GOSR2, LRRC37A2 (golgi SNAP receptor complex member 2| leucine rich repeat containing 37 member A2). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; Progressive myoclonic epilepsy type 6